AI Outperforms Biopsy in Cancer Diagnosis: Lancet Study

Artificial intelligence (AI) has been found to be nearly twice as accurate as a biopsy in assessing the aggressiveness of certain cancers, according to a study by the Royal Marsden NHS foundation trust and the Institute of Cancer Research. The AI algorithm was particularly effective in grading the aggressiveness of sarcomas, a rare form of cancer that develops in connective tissues. By providing clinicians with a more accurate way of grading tumors, AI could improve outcomes for patients by identifying high-risk individuals more quickly and sparing low-risk patients unnecessary treatments. The algorithm could potentially be applied to other types of cancer in the future.